Mesodermal ALK5 controls lung myofibroblast versus lipofibroblast cell fate© 2016 Li et al.Background:
Epithelial-mesenchymal cross talk is centerpiece in the development
Mesodermal ALK5 controls lung myofibroblast versus lipofibroblast cell fate© 2016 Li et al.Background:
Epithelial-mesenchymal cross talk is centerpiece in the development
Evidence for the involvement of fibroblast growth factor 10 in lipofibroblast formation during embryonic lung developmentAl Alam D.,
El Agha E.,
Sakurai R.,
Kheirollahi V.,
Moiseenko A.,
Danopoulos S.,
Shrestha A.,
Schmoldt C.,
Quantius J.,
Herold S.,
Chao C.,
Tiozzo C.,
De Langhe S.,
Plikus M.,
Thornton M.,
Grubbs B.,
Minoo P.,
Rehan V.,
Bellusci S. fibroblasts (lipofibroblasts) are increasingly recognized as an important component of the
epithelial stem
Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasisKudinov A.,
Deneka A.,
Nikonova A.,
Beck T.,
Ahn Y.,
Liu X.,
Martinez C.,
Schultz F.,
Reynolds S.,
Yang D.,
Cai K.,
Yaghmour K.,
Baker K.,
Egleston B.,
Nicolas E.,
Chikwem A.,
Andrianov G.,
Singh S.,
Borghaei H.,
Serebriiskii I.,
Gibbons D.,
Kurie J.,
Golemis E.,
Boumber Y. translational targets associated with
epithelial-mesenchymal transition, including the TGF-β receptor 1 (TGFβR1
Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study the host cell through a specific receptor (Angiotensin-converting enzyme 2) expressed on
epithelial cells
Potential therapeutic application of mesenchymal stem cells in ophthalmology-clinical and clinical ophthalmology studies where
mesenchymal stem cells are applied and various methods